Patents by Inventor Takeyoshi Yamashita

Takeyoshi Yamashita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI FGF23 ANTIBODY AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20190106485
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Application
    Filed: December 18, 2018
    Publication date: April 11, 2019
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Yuji Yamazaki, Itaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • Anti FGF23 antibody and a pharmaceutical composition comprising the same
    Patent number: 10202446
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: February 12, 2019
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Yuji Yamazaki, Itaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • ANTI FGF23 ANTIBODY AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20160159895
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Application
    Filed: February 10, 2016
    Publication date: June 9, 2016
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Yuji Yamazaki, ltaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • Anti FGF23 antibody and a pharmaceutical composition comprising the same
    Patent number: 9290569
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Grant
    Filed: February 2, 2011
    Date of Patent: March 22, 2016
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Yuji Yamazaki, Itaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • ANTI FGF23 ANTIBODY AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20110182913
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Application
    Filed: February 2, 2011
    Publication date: July 28, 2011
    Inventors: Yuji Yamazaki, Itaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • Method for treating hypophosphatemic bone diseases using FGF-23 antibody
    Patent number: 7981419
    Abstract: A method for treating a hypophosphatemic bone disease, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition, which contains an antibody that binds to an FGF-23 polypeptide and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: July 19, 2011
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Takeyoshi Yamashita, Takashi Shimada, Satoru Mizutani, Seiji Fukumoto
  • Antibody against fibroblast growth factor-23
    Patent number: 7923012
    Abstract: The purpose of the present invention is to provide an antibody against fibroblast growth factor 23.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: April 12, 2011
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Yuji Yamazaki, Takashi Shimada, Takeyoshi Yamashita
  • Anti FGF23 antibody and a pharmaceutical composition comprising the same
    Patent number: 7883705
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: February 8, 2011
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Yuji Yamazaki, Itaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • ANTI FGF23 ANTIBODY AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20090148461
    Abstract: To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
    Type: Application
    Filed: February 13, 2008
    Publication date: June 11, 2009
    Inventors: Yuji Yamazaki, Itaru Urakawa, Hitoshi Yoshida, Yukiko Aono, Takeyoshi Yamashita, Takashi Shimada, Hisashi Hasegawa
  • POLYPEPTIDE REGULATING PHOSPHATE METABOLISM, CALCIUM METABOLISM, CALCIFICATION AND VITAMIN D METABOLISM AND DNAS ENCODING THE SAME
    Publication number: 20090110677
    Abstract: A DNA, which encodes the following polypeptide (a), (b), (c) or (d): (a) a polypeptide consisting of an amino acid sequence represented by SEQ ID NO: 2 or 4, (b) a polypeptide consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 or 4 by deletion, substitution or addition of one or several amino acids, and having hypophosphatemia-inducing activity, phosphate transport-suppressing activity, calcification-suppressing activity or in vivo vitamin D metabolism-regulating activity, (c) a polypeptide consisting of a partial sequence of the amino acid sequence represented by SEQ ID NO: 2, wherein the above partial sequence contains an amino acid sequence at least ranging from the 34th to 201st amino acids in the above amino acid sequence, or (d) a polypeptide consisting of a partial sequence of the amino acid sequence represented by SEQ ID NO: 2, wherein the above partial sequence: (i) contains an amino acid sequence ranging from at least the 34th to 201st amino aci
    Type: Application
    Filed: December 1, 2008
    Publication date: April 30, 2009
    Inventors: Takeyoshi YAMASHITA, Takashi Shimada, Satoru Mizutani, Seiji Fukumoto
  • Antibody against fibroblast growth factor-23
    Publication number: 20050048058
    Abstract: The purpose of the present invention is to provide an antibody against fibroblast growth factor 23.
    Type: Application
    Filed: January 6, 2003
    Publication date: March 3, 2005
    Inventors: Yuji Yamazaki, Takashi Shimada, Takeyoshi Yamashita
  • Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
    Publication number: 20040082506
    Abstract: A DNA, which encodes the following polypeptide (a), (b), (c) or (d):
    Type: Application
    Filed: July 21, 2003
    Publication date: April 29, 2004
    Inventors: Takeyoshi Yamashita, Takashi Shimada, Satoru Mizutani, Seiji Fukumoto